$HOV
HOVNANIAN ENTERPRISES INC Stock $hov

$hov Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922000287 Filed on January 04, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$814.3M	$2.783B	$683.4M
YoY Change	19.17%	18.73%	-4.24%
Cost Of Revenue	$638.5M	$2.198B	$542.8M
YoY Change	17.63%	13.79%	-8.42%
Gross Profit	$175.9M	$584.9M	$140.5M
YoY Change	25.17%	41.87%	16.21%
Gross Profit Margin	21.6%	21.02%	20.56%
Selling, General & Admin	$70.02M	$276.6M	$65.60M
YoY Change	6.74%	14.39%	21.71%
% of Gross Profit	39.82%	47.29%	46.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.189M	$5.280M	$1.400M
YoY Change	-15.07%	-0.45%	7.69%
% of Gross Profit	0.68%	0.9%	1.0%
Operating Expenses	$70.53M	$278.3M	$66.00M
YoY Change	6.86%	14.58%	21.55%
Operating Profit	$105.3M	$306.6M	$74.50M
YoY Change	41.39%	80.99%	11.86%
Interest Expense	-$24.45M	$161.8M	-$32.10M
YoY Change	-23.85%	-9.16%	29.44%
% of Operating Profit	-23.21%	52.77%	-43.09%
Other Income/Expense, Net
YoY Change
Pretax Income	$77.45M	$189.9M	$42.44M
YoY Change	82.46%	242.78%	-7343.0%
Income Tax	$24.97M	-$418.0M	$1.810M
% Of Pretax Income	32.24%	-220.12%	4.26%
Net Earnings	$52.48M	$607.8M	$40.63M
YoY Change	29.15%	1093.48%	-2348.7%
Net Earnings / Revenue	6.44%	21.84%	5.95%
Basic Earnings Per Share		$87.50
Diluted Earnings Per Share	$8.111M	$85.86	$5.54
COMMON SHARES
Basic Shares Outstanding		6.287M
Diluted Shares Outstanding		6.395M	6.699M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$246.0M	$246.0M	$262.5M
YoY Change	-6.3%	-6.3%	100.38%
Cash & Equivalents	$311.4M	$246.0M	$309.5M
Short-Term Investments
Other Short-Term Assets	$38.34M	$38.34M	$58.70M
YoY Change	-34.68%	-0.93%	28.45%
Inventory	$1.254B	$1.254B	$1.196B
Prepaid Expenses
Receivables	$39.93M	$39.93M	$33.70M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.579B	$1.579B	$1.551B
YoY Change	1.79%	3.12%	2.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.74M	$36.58M	$18.19M
YoY Change	3.03%	-4.24%	-9.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$60.90M	$60.90M	$103.2M
YoY Change	-40.99%	-40.99%	-18.74%
Other Assets	$441.8M	$441.8M	$14.70M
YoY Change	2905.22%	2905.22%	-29.67%
Total Long-Term Assets	$742.0M	$742.0M	$276.6M
YoY Change	168.22%	150.17%	-24.69%
TOTAL ASSETS
Total Short-Term Assets	$1.579B	$1.579B	$1.551B
Total Long-Term Assets	$742.0M	$742.0M	$276.6M
Total Assets	$2.321B	$2.321B	$1.827B
YoY Change	26.99%	26.99%	-2.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$163.9M	$163.9M	$148.5M
YoY Change	10.37%	10.37%	4.8%
Accrued Expenses	$167.6M	$167.6M	$135.9M
YoY Change	23.29%	23.29%	87.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$403.6M	$403.6M	$336.5M
YoY Change	19.94%	19.94%	33.37%
LONG-TERM LIABILITIES
Long-Term Debt	$1.373B	$1.373B	$1.566B
YoY Change	-12.31%	-12.31%	-8.02%
Other Long-Term Liabilities	$368.1M	$368.1M	$360.6M
YoY Change	2.07%	2.07%	-13.38%
Total Long-Term Liabilities	$1.742B	$1.742B	$1.927B
YoY Change	-9.62%	-9.62%	-9.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$403.6M	$403.6M	$336.5M
Total Long-Term Liabilities	$1.742B	$1.742B	$1.927B
Total Liabilities	$2.145B	$2.146B	$2.263B
YoY Change	-5.23%	-5.24%	-4.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$567.2M		-$1.175B
YoY Change	-51.73%		-4.15%
Common Stock	$722.1M		$718.1M
YoY Change	0.56%		0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$115.4M		$115.4M
YoY Change	0.0%		0.0%
Treasury Stock Shares
Shareholders Equity	$174.9M	$174.9M	-$436.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.321B	$2.321B	$1.827B
YoY Change	26.99%	26.99%	-2.87%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$52.48M	$607.8M	$40.63M
YoY Change	29.15%	1093.48%	-2348.7%
Depreciation, Depletion And Amortization	$1.189M	$5.280M	$1.400M
YoY Change	-15.07%	-0.45%	7.69%
Cash From Operating Activities	$127.9M	$210.2M	$100.0M
YoY Change	27.94%	-28.21%	1011.11%
INVESTING ACTIVITIES
Capital Expenditures	-$2.053M	$5.942M	-$800.0K
YoY Change	156.63%	75.8%	-11.11%
Acquisitions
YoY Change
Other Investing Activities	$4.070M	$14.94M	$21.20M
YoY Change	-80.8%	171.6%	909.52%
Cash From Investing Activities	$2.017M	$8.996M	$20.40M
YoY Change	-90.11%	320.37%	1600.0%
FINANCING ACTIVITIES
Cash Dividend Paid		$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-53.63M	-$217.3M	-57.30M
YoY Change	-6.41%	29.5%	-221.14%
NET CHANGE
Cash From Operating Activities	127.9M	$210.2M	100.0M
Cash From Investing Activities	2.017M	$8.996M	20.40M
Cash From Financing Activities	-53.63M	-$217.3M	-57.30M
Net Change In Cash	76.33M	$1.936M	63.10M
YoY Change	20.97%	-98.48%	9.74%
FREE CASH FLOW
Cash From Operating Activities	$127.9M	$210.2M	$100.0M
Capital Expenditures	-$2.053M	$5.942M	-$800.0K
Free Cash Flow	$130.0M	$204.3M	$100.8M
YoY Change	28.96%	-29.43%	918.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5600
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5600
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5600
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5600
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	140000000	USD
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	140000000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6800000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	300000	USD
CY2021	hov	Number Of Communities Performed Detailed Impairment Calculations NumberOfCommunitiesPerformedDetailedImpairmentCalculations	3	pure
CY2020	hov	Number Of Communities Performed Detailed Impairment Calculations NumberOfCommunitiesPerformedDetailedImpairmentCalculations	3	pure
CY2021	hov	Conversion Of Stock From Class B To Class A Conversion Ratio ConversionOfStockFromClassBToClassAConversionRatio	1	pure
CY2005Q3	hov	Preferred Stock Depositary Shares Number Of Shares Of Preferred Stock In Each Depositary Share PreferredStockDepositarySharesNumberOfSharesOfPreferredStockInEachDepositaryShare	1
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q4	hov	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Installments SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfInstallments	4	pure
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020Q4	hov	General Liability Insurance Deductible GeneralLiabilityInsuranceDeductible	20000000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	115360000	USD
CY2020Q4	hov	Bodily Injury Insurance Deductible BodilyInjuryInsuranceDeductible	250000	USD
CY2020Q4	hov	Bodily Injury Insurance Limit BodilyInjuryInsuranceLimit	5000000	USD
CY2020Q4	hov	Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims	20000000	USD
CY2021Q3	hov	Number Of Joint Ventures From Which Remaining Equity Interest Purchased NumberOfJointVenturesFromWhichRemainingEquityInterestPurchased	1	pure
CY2021Q3	hov	Number Of Communities Taken Control Of From Joint Ventures NumberOfCommunitiesTakenControlOfFromJointVentures	4	pure
CY2021Q3	hov	Number Of Active Communities Taken Control Of From Joint Ventures NumberOfActiveCommunitiesTakenControlOfFromJointVentures	3	pure
CY2021Q2	hov	Number Of New Joint Ventures NumberOfNewJointVentures	2	pure
CY2020Q1	hov	Number Of Owned Communities Transferred To The Joint Venture NumberOfOwnedCommunitiesTransferredToTheJointVenture	8	pure
CY2020Q1	hov	Number Of Owned Active Communities Transferred To The Joint Venture NumberOfOwnedActiveCommunitiesTransferredToTheJointVenture	4	pure
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2020	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	425678000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Assets Assets	2320508000	USD
CY2020Q4	us-gaap	Assets Assets	1827342000	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	3851000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	3832000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2145124000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2263436000	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	135299000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	135299000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	722118000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	718110000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-567228000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1175045000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	115360000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174897000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-436929000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	487000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	835000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	175384000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-436094000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2320508000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1827342000	USD
CY2021	us-gaap	Revenues Revenues	2782857000	USD
CY2020	us-gaap	Revenues Revenues	2343901000	USD
CY2019	us-gaap	Revenues Revenues	2016916000	USD
CY2021	hov	Corporate General And Administrative CorporateGeneralAndAdministrative	106694000	USD
CY2020	hov	Corporate General And Administrative CorporateGeneralAndAdministrative	80553000	USD
CY2019	hov	Corporate General And Administrative CorporateGeneralAndAdministrative	66364000	USD
CY2021	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	77716000	USD
CY2020	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	103801000	USD
CY2019	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	90056000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1740000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1096000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1561000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2598097000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	2318400000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	2043080000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3748000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13337000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42436000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8849000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16565000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28932000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	189861000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55403000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39668000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-417956000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4475000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2449000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	607817000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	50928000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-42117000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	87.50
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.48
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.06
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6287000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6189000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5968000
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	85.86
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.03
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.06
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6395000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6584000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5968000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-453504000	USD
CY2019	hov	Stock Options Amortization And Issuance Value StockOptionsAmortizationAndIssuanceValue	808000	USD
CY2019	hov	Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue	-125000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4475000	USD
CY2019	hov	Conversion Of Stock Value ConversionOfStockValue	0	USD
CY2019	hov	Changes In Noncontrolling Interest In Consolidated Joint Ventures ChangesInNoncontrollingInterestInConsolidatedJointVentures	687000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-42117000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-489776000	USD
CY2020	hov	Stock Options Amortization And Issuance Value StockOptionsAmortizationAndIssuanceValue	387000	USD
CY2020	hov	Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue	2219000	USD
CY2020	hov	Conversion Of Stock Value ConversionOfStockValue	0	USD
CY2020	hov	Changes In Noncontrolling Interest In Consolidated Joint Ventures ChangesInNoncontrollingInterestInConsolidatedJointVentures	148000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	50928000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-436094000	USD
CY2021	hov	Stock Options Amortization And Issuance Value StockOptionsAmortizationAndIssuanceValue	-41000	USD
CY2021	hov	Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue	4050000	USD
CY2021	hov	Conversion Of Stock Value ConversionOfStockValue	0	USD
CY2021	hov	Changes In Noncontrolling Interest In Consolidated Joint Ventures ChangesInNoncontrollingInterestInConsolidatedJointVentures	-348000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	607817000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	175384000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	607817000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	50928000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-42117000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5280000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5304000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4172000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7668000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2779000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	721000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	242000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1891000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8128000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-92000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	81000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	25000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8849000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	31456000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	25332000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16565000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28932000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	9709000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	35387000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	29919000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3748000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13337000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42436000	USD
CY2021	hov	Noncontrolling Interest Income In Consolidated Joint Venture NoncontrollingInterestIncomeInConsolidatedJointVenture	-430000	USD
CY2020	hov	Noncontrolling Interest Income In Consolidated Joint Venture NoncontrollingInterestIncomeInConsolidatedJointVenture	-148000	USD
CY2019	hov	Noncontrolling Interest Income In Consolidated Joint Venture NoncontrollingInterestIncomeInConsolidatedJointVenture	-4000	USD
CY2021	hov	Inventory Impairments And Land Option Cost Write Offs InventoryImpairmentsAndLandOptionCostWriteOffs	3630000	USD
CY2020	hov	Inventory Impairments And Land Option Cost Write Offs InventoryImpairmentsAndLandOptionCostWriteOffs	8813000	USD
CY2019	hov	Inventory Impairments And Land Option Cost Write Offs InventoryImpairmentsAndLandOptionCostWriteOffs	6288000	USD
CY2021	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1490099000	USD
CY2020	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1306279000	USD
CY2019	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1089825000	USD
CY2021	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1443355000	USD
CY2020	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1367903000	USD
CY2019	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1054535000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3016000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-20519000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15911000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	35514000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-87897000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	220608000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	425678000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-0	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-0	USD
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	19000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1531000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1033000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	20009000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	12414000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5786000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	71370000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33576000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2665000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	210213000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	292828000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-249127000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	32000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	112000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	29000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5942000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3380000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4005000	USD
CY2021	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	16550000	USD
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	19924000	USD
CY2019	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	13256000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	8925000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8996000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	311396000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	309460000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	182266000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2140000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8307000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	252930000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	278577000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	318462000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	262609000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	348371000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	209445000	USD
CY2021	hov	Proceeds From Model Sale Leaseback Financing Programs ProceedsFromModelSaleLeasebackFinancingPrograms	7606000	USD
CY2020	hov	Proceeds From Model Sale Leaseback Financing Programs ProceedsFromModelSaleLeasebackFinancingPrograms	19200000	USD
CY2019	hov	Proceeds From Model Sale Leaseback Financing Programs ProceedsFromModelSaleLeasebackFinancingPrograms	33188000	USD
CY2021	hov	Payments For Model Sale Leaseback Financing Programs PaymentsForModelSaleLeasebackFinancingPrograms	23677000	USD
CY2020	hov	Payments For Model Sale Leaseback Financing Programs PaymentsForModelSaleLeasebackFinancingPrograms	23646000	USD
CY2019	hov	Payments For Model Sale Leaseback Financing Programs PaymentsForModelSaleLeasebackFinancingPrograms	25791000	USD
CY2021	hov	Proceeds From Land Bank Financing Program ProceedsFromLandBankFinancingProgram	35282000	USD
CY2020	hov	Proceeds From Land Bank Financing Program ProceedsFromLandBankFinancingProgram	68060000	USD
CY2019	hov	Proceeds From Land Bank Financing Program ProceedsFromLandBankFinancingProgram	104961000	USD
CY2021	hov	Payments For Land Bank Financing Program PaymentsForLandBankFinancingProgram	88458000	USD
CY2020	hov	Payments For Land Bank Financing Program PaymentsForLandBankFinancingProgram	73999000	USD
CY2019	hov	Payments For Land Bank Financing Program PaymentsForLandBankFinancingProgram	33902000	USD
CY2021	hov	Proceeds From Partner Distributions To Consolidated Joint Venture ProceedsFromPartnerDistributionsToConsolidatedJointVenture	40000	USD
CY2020	hov	Proceeds From Partner Distributions To Consolidated Joint Venture ProceedsFromPartnerDistributionsToConsolidatedJointVenture	0	USD
CY2019	hov	Proceeds From Partner Distributions To Consolidated Joint Venture ProceedsFromPartnerDistributionsToConsolidatedJointVenture	683000	USD
CY2021	hov	Payments For Partner Distributions To Consolidated Joint Venture PaymentsForPartnerDistributionsToConsolidatedJointVenture	818000	USD
CY2020	hov	Payments For Partner Distributions To Consolidated Joint Venture PaymentsForPartnerDistributionsToConsolidatedJointVenture	-0	USD
CY2019	hov	Payments For Partner Distributions To Consolidated Joint Venture PaymentsForPartnerDistributionsToConsolidatedJointVenture	-0	USD
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	182726000	USD
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	21240000	USD
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	570032000	USD
CY2021	hov	Payment Of Financing Costs For Debt Issuance And Land Bank Financing PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing	2587000	USD
CY2020	hov	Payment Of Financing Costs For Debt Issuance And Land Bank Financing PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing	13278000	USD
CY2019	hov	Payment Of Financing Costs For Debt Issuance And Land Bank Financing PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing	16748000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-217273000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-167774000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	206708000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1936000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127194000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-50726000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	309460000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	182266000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	232992000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	87227000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	89484000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	109107000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7669000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3013000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3483000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	311396000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	309460000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	182266000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><b><em style="font: inherit;">2.</em> Business</b></p> <p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">HEI conducts all of its homebuilding and financial services operations through its subsidiaries (references herein to the “Company”, “we”, “us” or “our” refer to HEI and its consolidated subsidiaries and should be understood to reflect the consolidated business of HEI’s subsidiaries). Our operations consist of homebuilding, financial services and corporate. Our homebuilding operations are made up of six reportable segments defined as Northeast, Mid-Atlantic, Midwest, Southeast, Southwest and West. Homebuilding operations comprise the substantial part of our business, representing approximately <span style="-sec-ix-hidden:c798831381"><span style="-sec-ix-hidden:c79883138">97</span></span>% of consolidated revenues for each of the years ended <em style="font: inherit;"> October 31, 2021</em>, <em style="font: inherit;">2020</em> and <em style="font: inherit;">2019.</em> HEI is a Delaware corporation, which through its subsidiaries, was building and selling homes in Arizona, California, Delaware, Florida, Georgia, Illinois, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Washington, D.C. and West Virginia, including in 124 consolidated active selling communities at <em style="font: inherit;"> October 31, 2021</em>. Our homebuilding subsidiaries offer a wide variety of homes that are designed to appeal to <em style="font: inherit;">first</em>-time buyers, <em style="font: inherit;">first</em> and <em style="font: inherit;">second</em>-time move-up buyers, luxury buyers, active lifestyle buyers and empty nesters. Our financial services operations, which are a reportable segment, provide mortgage banking and title services to the homebuilding operations’ customers. Our financial services subsidiaries do <em style="font: inherit;">not</em> typically retain or service the mortgages that they originate but rather sell the mortgages and related servicing rights to investors. Corporate primarily includes the operations of our corporate office whose primary purpose is to provide executive services, accounting, information services, human resources, management reporting, training, cash management, internal audit, risk management, and administration of process redesign, quality, and safety.</p> <p style="margin: 0pt; text-align: left; font-family: Times New Roman; font-size: 6pt;"> </p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">See Note <em style="font: inherit;">10</em> “Operating and Reporting Segments” for further disclosure of our reportable segments.</p>
CY2021Q4	hov	Number Of Communities NumberOfCommunities	124	pure
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt; text-align: left; font-family: Times New Roman; font-size: 10pt;"/> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: Times New Roman; font-size: 10pt;"><i>Use of Estimates</i> - The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and these differences could have a significant impact on the financial statements.</p>
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15700000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15500000	USD
CY2021Q4	hov	Number Of Communities Mothballed NumberOfCommunitiesMothballed	6	pure
CY2020Q4	hov	Number Of Communities Mothballed NumberOfCommunitiesMothballed	12	pure
CY2021Q4	hov	Inventory Real Estate Mothballed Communities InventoryRealEstateMothballedCommunities	4300000	USD
CY2020Q4	hov	Inventory Real Estate Mothballed Communities InventoryRealEstateMothballedCommunities	11400000	USD
CY2021Q4	hov	Inventory Real Estate Mothballed Communities Accumulated Impairment Charges InventoryRealEstateMothballedCommunitiesAccumulatedImpairmentCharges	57500000	USD
CY2020Q4	hov	Inventory Real Estate Mothballed Communities Accumulated Impairment Charges InventoryRealEstateMothballedCommunitiesAccumulatedImpairmentCharges	122200000	USD
CY2020Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	2000000.0	USD
CY2021Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	0	USD
CY2021Q4	hov	General Liability Insurance Deductible GeneralLiabilityInsuranceDeductible	20000000	USD
CY2021Q4	hov	Bodily Injury Insurance Deductible BodilyInjuryInsuranceDeductible	250000	USD
CY2021Q4	hov	Bodily Injury Insurance Limit BodilyInjuryInsuranceLimit	5000000	USD
CY2021Q4	hov	Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims	20000000	USD
CY2020Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	65010000	USD
CY2019Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	71264000	USD
CY2018Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	68117000	USD
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	155514000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	176457000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	165906000	USD
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	84100000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	74330000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	70725000	USD
CY2021	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	77716000	USD
CY2020	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	103801000	USD
CY2019	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	90056000	USD
CY2021	hov	Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture	3667000	USD
CY2020	hov	Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture	4580000	USD
CY2019	hov	Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture	1978000	USD
CY2021	hov	Real Estate Inventory Capitalized Interest Costs Interest Acquired From Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestAcquiredFromJointVenture	3118000	USD
CY2020	hov	Real Estate Inventory Capitalized Interest Costs Interest Acquired From Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestAcquiredFromJointVenture	0	USD
CY2019	hov	Real Estate Inventory Capitalized Interest Costs Interest Acquired From Joint Venture RealEstateInventoryCapitalizedInterestCostsInterestAcquiredFromJointVenture	0	USD
CY2021Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	58159000	USD
CY2020Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	65010000	USD
CY2019Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	71264000	USD
CY2021	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	77716000	USD
CY2020	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	103801000	USD
CY2019	hov	Real Estate Inventory Expense Not Eligible For Capitalization RealEstateInventoryExpenseNotEligibleForCapitalization	90056000	USD
CY2021	us-gaap	Interest Paid InterestPaid	2102000	USD
CY2020	us-gaap	Interest Paid InterestPaid	2165000	USD
CY2019	us-gaap	Interest Paid InterestPaid	2536000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-7409000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	16482000	USD
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-16515000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	87227000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	89484000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	109107000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	9800000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	12900000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	17100000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10500000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12000000.0	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1500000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	200000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	10521000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3029000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	10507000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	9598000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	9257000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	6800000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.094	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.096	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5942000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3201000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2435000	USD
CY2021Q4	hov	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	1403000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	21981000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	67295000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64543000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48559000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46358000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18736000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18185000	USD
CY2021Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	136500000	USD
CY2020Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	87900000	USD
CY2021Q4	hov	Number Of Loans Reserved For NumberOfLoansReservedFor	14	pure
CY2020Q4	hov	Number Of Loans Reserved For NumberOfLoansReservedFor	15	pure
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Writedown Or Reserve Amount1 MortgageLoansOnRealEstateWritedownOrReserveAmount1	1458000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate Writedown Or Reserve Amount1 MortgageLoansOnRealEstateWritedownOrReserveAmount1	1268000	USD
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	228000	USD
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	196000	USD
CY2021	us-gaap	Allowance For Loan And Lease Losses Adjustments Net AllowanceForLoanAndLeaseLossesAdjustmentsNet	-54000	USD
CY2020	us-gaap	Allowance For Loan And Lease Losses Adjustments Net AllowanceForLoanAndLeaseLossesAdjustmentsNet	-6000	USD
CY2021	hov	Payments Settlements PaymentsSettlements	0	USD
CY2020	hov	Payments Settlements PaymentsSettlements	0	USD
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Writedown Or Reserve Amount1 MortgageLoansOnRealEstateWritedownOrReserveAmount1	1632000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Writedown Or Reserve Amount1 MortgageLoansOnRealEstateWritedownOrReserveAmount1	1458000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1254852000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1435749000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	10769000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	17521000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17248000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	22160000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	1248373000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	1431110000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1043683000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	211169000	USD
CY2021	us-gaap	Revenues Revenues	2782857000	USD
CY2020	us-gaap	Revenues Revenues	2343901000	USD
CY2019	us-gaap	Revenues Revenues	2016916000	USD
CY2021	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	5942000	USD
CY2020	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	3380000	USD
CY2019	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	4005000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8849000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16565000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28932000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1254852000	USD
CY2021Q4	hov	Debt Covenant Fixed Charge Coverage Ratio Minimum DebtCovenantFixedChargeCoverageRatioMinimum	2.0	pure
CY2021Q4	hov	Secured Debt Leverage Ratio SecuredDebtLeverageRatio	4.0	pure
CY2021Q4	hov	Debt Covenant Fixed Charge Coverage Ratio Minimum DebtCovenantFixedChargeCoverageRatioMinimum	2.0	pure
CY2021Q4	hov	Secured Debt Leverage Ratio SecuredDebtLeverageRatio	4.0	pure
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2700000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42400000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	189861000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55403000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39668000	USD
CY2021Q4	us-gaap	Assets Assets	2320508000	USD
CY2020Q4	us-gaap	Assets Assets	1827342000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	60897000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	103164000	USD
CY2021	us-gaap	Interest Expense InterestExpense	161781000	USD
CY2020	us-gaap	Interest Expense InterestExpense	178096000	USD
CY2019	us-gaap	Interest Expense InterestExpense	161115000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5280000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5304000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4172000	USD
CY2021Q4	hov	Income Taxes Receivable Payable IncomeTaxesReceivablePayable	-421827000	USD
CY2020Q4	hov	Income Taxes Receivable Payable IncomeTaxesReceivablePayable	3832000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7722000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	3020000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4475000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2449000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7722000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4475000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2449000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-335608000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-90070000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-425678000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-417956000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4475000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2449000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-418000000.0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4500000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	425700000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	205600000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	189900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55400000	USD
CY2021Q4	hov	Contract Backlog ContractBacklog	1600000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	34973000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	42120000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	4483000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	3870000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	5671000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4848000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	12464000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	9554000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1420000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3793000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2582000	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3930000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	743000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	263366000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	299854000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	177163000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	425678000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	181050000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5136000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3259000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	527233000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	577534000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101555000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	577534000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.106	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.050	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.036	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.532	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.424	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2.485	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.833	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.208	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.002	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.005	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.005	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.000	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.070	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.010	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.201	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.080	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.061	pure
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	200000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.48
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	85.86
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.03
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.06
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	84000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	60000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	32000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	300000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	700000	USD
CY2021	hov	Number Of Communities Evaluated For Impairment NumberOfCommunitiesEvaluatedForImpairment	374	pure
CY2020	hov	Number Of Communities Evaluated For Impairment NumberOfCommunitiesEvaluatedForImpairment	354	pure
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2000000.0	USD
CY2021	hov	Land Option Write Offs LandOptionWriteOffs	1600000	USD
CY2020	hov	Land Option Write Offs LandOptionWriteOffs	6800000	USD
CY2019	hov	Land Option Write Offs LandOptionWriteOffs	3600000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	607817000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	50928000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-42117000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	57676000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4652000	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	550141000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	46276000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42117000	USD
CY2021	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	57676000	USD
CY2020	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	4652000	USD
CY2019	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	0	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	58687000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4652000	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	549130000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	46276000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-42117000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6287000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6189000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5968000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	108000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	395000
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6395000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6584000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5968000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	87.50
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	145553
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	147019
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	7.85
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	157.00
CY2021Q4	hov	Common Stock Dividends Percent Of Increase From Class A To Class B CommonStockDividendsPercentOfIncreaseFromClassAToClassB	1.10	pure
CY2018Q1	hov	Shareholder Ownership Percentage Of Increase ShareholderOwnershipPercentageOfIncrease	0.50	pure
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	7000000.0	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	7400000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	7300000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7700000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	5200000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2800000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2600000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	289391
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	47.02
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	331481
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	53.93
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	278569
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	73.76
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	110975
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.44
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	77607
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	35.30
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1650
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.80
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6560
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	26.24
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2038
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	53.96
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3900
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	48.03
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	35530
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	115.28
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	56025
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	64.41
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	206234
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.67
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	289391
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	47.02
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	331481
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	53.93
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	125528
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4800000	USD
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	14342000	USD
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20163000	USD
CY2021	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-988000	USD
CY2020	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-2651000	USD
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	94916000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	86417000	USD
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.46
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.82
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	25.34
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	36.07
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	206234
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	51.67
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y10M24D
CY2021	hov	Sharebased Compensation Arrangement By Sharebased Payment Award Participants Years Of Service SharebasedCompensationArrangementBySharebasedPaymentAwardParticipantsYearsOfService	P15Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	300000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12500000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
CY2021	hov	Cash Received From Subcontractors For Owner Controlled Insurance Program CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram	5500000	USD
CY2020	hov	Cash Received From Subcontractors For Owner Controlled Insurance Program CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram	4400000	USD
CY2021Q4	hov	General Liability Insurance Deductible GeneralLiabilityInsuranceDeductible	20000000	USD
CY2021Q4	hov	Bodily Injury Insurance Deductible BodilyInjuryInsuranceDeductible	250000	USD
CY2021Q4	hov	Bodily Injury Insurance Limit BodilyInjuryInsuranceLimit	5000000	USD
CY2021Q4	hov	Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims	20000000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	86417000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	89371000	USD
CY2021Q4	hov	Increase Decrease In Construction Defect Reserves IncreaseDecreaseInConstructionDefectReserves	1600000	USD
CY2020Q4	hov	Increase Decrease In Construction Defect Reserves IncreaseDecreaseInConstructionDefectReserves	2500000	USD
CY2021	hov	Payments By Insurance Companies For Claims PaymentsByInsuranceCompaniesForClaims	100000	USD
CY2020	hov	Payments By Insurance Companies For Claims PaymentsByInsuranceCompaniesForClaims	100000	USD
CY2021Q4	hov	Deposits Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities DepositsAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities	100100000	USD
CY2021Q4	hov	Purchase Price Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities PurchasePriceAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities	1500000000	USD
CY2021Q3	hov	Payments To Acquire Remaining Equity Interest In Unconsolidated Joint Venture PaymentsToAcquireRemainingEquityInterestInUnconsolidatedJointVenture	6300000	USD
CY2021Q2	hov	Number Of Owned Communities Transferred To The Joint Venture NumberOfOwnedCommunitiesTransferredToTheJointVenture	6	pure
CY2021Q2	hov	Number Of Owned Active Communities Transferred To The Joint Venture NumberOfOwnedActiveCommunitiesTransferredToTheJointVenture	3	pure
CY2021Q2	hov	Proceeds From Transfer Of Land To Joint Venture ProceedsFromTransferOfLandToJointVenture	21200000	USD
CY2020Q1	hov	Proceeds From Transfer Of Land To Joint Venture ProceedsFromTransferOfLandToJointVenture	29800000	USD
CY2019Q3	hov	Number Of Owned Communities Transferred To The Joint Venture NumberOfOwnedCommunitiesTransferredToTheJointVenture	1	pure
CY2019Q3	hov	Proceeds From Transfer Of Land To Joint Venture ProceedsFromTransferOfLandToJointVenture	15900000	USD
CY2021Q4	hov	Joint Venture Total Debt To Capitalization Ratio JointVentureTotalDebtToCapitalizationRatio	0.33	pure
CY2021Q4	hov	Loans Held For Sale Mortgages Unpaid Principal LoansHeldForSaleMortgagesUnpaidPrincipal	146500000	USD
CY2020Q4	hov	Loans Held For Sale Mortgages Unpaid Principal LoansHeldForSaleMortgagesUnpaidPrincipal	100400000	USD
CY2021Q4	us-gaap	Other Commitment OtherCommitment	24000000.0	USD
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2000000.0	USD
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2000000.0	USD
CY2019	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2700000	USD
CY2021Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1266892000	USD
CY2020Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1241570000	USD

Files In Submission

Name	View Source	Status
0001437749-22-000287-index-headers.html	Edgar Link	pending
0001437749-22-000287-index.html	Edgar Link	pending
0001437749-22-000287.txt	Edgar Link	pending
0001437749-22-000287-xbrl.zip	Edgar Link	pending
ex_290255.htm	Edgar Link	pending
ex_290256.htm	Edgar Link	pending
ex_290257.htm	Edgar Link	pending
ex_290258.htm	Edgar Link	pending
ex_290259.htm	Edgar Link	pending
ex_290260.htm	Edgar Link	pending
ex_290261.htm	Edgar Link	pending
ex_290262.htm	Edgar Link	pending
ex_290263.htm	Edgar Link	pending
ex_290264.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hov-20211031.xsd	Edgar Link	pending
hov-20211031_cal.xml	Edgar Link	unprocessable
hov-20211031_def.xml	Edgar Link	unprocessable
hov-20211031_lab.xml	Edgar Link	unprocessable
hov-20211031_pre.xml	Edgar Link	unprocessable
hov20211031_10k.htm	Edgar Link	pending
hov20211031_10k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HOV
HOVNANIAN ENTERPRISES INC Stock $hov

2021 Q4 Form 10-K Financial Statement

#000143774922000287 Filed on January 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOV HOVNANIAN ENTERPRISES INC Stock $hov

2021 Q4 Form 10-K Financial Statement

#000143774922000287 Filed on January 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOV
HOVNANIAN ENTERPRISES INC Stock $hov